|
Apr 25
|
Zai Lab Presents Data Highlighting Potential of Internally Developed, Next-Generation Oncology Therapies at AACR 2025
|
|
Apr 23
|
Zai Lab to Present Data from Phase 1 Trial of DLL3-Targeted Antibody-Drug Conjugate (ADC) ZL-1310 at 2025 ASCO Annual Meeting
|
|
Apr 21
|
Zai Lab Announces Acceptance of Supplemental New Drug Application for Repotrectinib for Patients with NTRK-Positive Solid Tumors
|
|
Apr 15
|
All You Need to Know About Zai Lab Limited (ZLAB) Rating Upgrade to Buy
|
|
Apr 14
|
Zai Lab Limited (ZLAB) Moves 21.5% Higher: Will This Strength Last?
|
|
Apr 14
|
Zai Lab to Announce First Quarter 2025 Financial Results and Recent Corporate Updates on May 8, 2025
|
|
Apr 10
|
Zai Lab Limited (ZLAB): Among Stocks Insiders Sold in April After Trump’s Tariff Rollout
|
|
Mar 3
|
Zai Lab Announces Participation in Investor Conferences in March 2025
|
|
Mar 2
|
Zai Lab Limited (NASDAQ:ZLAB) Just Released Its Annual Results And Analysts Are Updating Their Estimates
|
|
Mar 1
|
Zai Lab Full Year 2024 Earnings: Beats Expectations
|
|
Feb 28
|
Zai Lab Ltd (ZLAB) Q4 2024 Earnings Call Highlights: Robust Revenue Growth and Path to Profitability
|
|
Feb 27
|
China Biotech's Sales Jump 66% But Bottom Line Misses Views
|
|
Feb 27
|
Zai Lab Announces Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Updates
|
|
Feb 26
|
Is Zai Lab Limited (ZLAB) the Best Performing Mid Cap Stock to Buy According to Analysts?
|
|
Jan 23
|
FDA grants ODD status to Zai Lab’s lung cancer treatment
|
|
Jan 23
|
Why Is Andreas Halvorsen Bullish On Zai Lab Limited (ZLAB) Now?
|
|
Jan 23
|
Zai Lab Receives Orphan Drug Designation from the U.S. FDA for ZL-1310 (DLL3 ADC) for the Treatment of Small Cell Lung Cancer (SCLC)
|
|
Jan 21
|
High Growth Tech Stocks To Explore In January 2025
|
|
Jan 21
|
Here’s Why Analysts Are Bullish on Zai Lab Limited (ZLAB)
|
|
Jan 20
|
Market Sentiment Around Loss-Making Zai Lab Limited (NASDAQ:ZLAB)
|